// App-Quantinova.ai

201 : Suitability for low-dose rivaroxaban based on compass trial: a district general hospital perspective

Researchers

Presenter

  • Muhammad Asad

Principal Investigators

  • Sayed Irfan Kazi

  • Mehak Gupta

  • Priyanth Alaguraja

  • Daniel McCaughey

  • Jayesh Makan

Medical Centers

  • Shrewsbury and Telford Hospital, Shrewsbury, UK

  • Keele University

  • Shrewsbury and Telford NHS Trust

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved